142 related articles for article (PubMed ID: 3199066)
21. Role of complement receptors 1 and 2 (CD35 and CD21), C3, C4, and C5 in survival by mice of Staphylococcus aureus bacteremia.
Cunnion KM; Benjamin DK; Hester CG; Frank MM
J Lab Clin Med; 2004 Jun; 143(6):358-65. PubMed ID: 15192652
[TBL] [Abstract][Full Text] [Related]
22. Resistance to listeriosis in mice that are deficient in the fifth component of complement.
Petit JC
Infect Immun; 1980 Jan; 27(1):61-7. PubMed ID: 6766905
[TBL] [Abstract][Full Text] [Related]
23. Schistosoma mansoni: development of primary infections in mice genetically deficient or intact in the fifth component of complement.
Ruppel A; Rother U; Diesfeld HJ
Parasitology; 1982 Oct; 85 (Pt 2)():315-23. PubMed ID: 7145473
[TBL] [Abstract][Full Text] [Related]
24. Complement Component 5 Mediates Development of Fibrosis, via Activation of Stellate Cells, in 2 Mouse Models of Chronic Pancreatitis.
Sendler M; Beyer G; Mahajan UM; Kauschke V; Maertin S; Schurmann C; Homuth G; Völker U; Völzke H; Halangk W; Wartmann T; Weiss FU; Hegyi P; Lerch MM; Mayerle J
Gastroenterology; 2015 Sep; 149(3):765-76.e10. PubMed ID: 26001927
[TBL] [Abstract][Full Text] [Related]
25. Requisite role for complement C5 and the C5a receptor in granulomatous response to mycobacterial glycolipid trehalose 6,6'-dimycolate.
Borders CW; Courtney A; Ronen K; Pilar Laborde-Lahoz M; Guidry TV; Hwang SA; Olsen M; Hunter RL; Hollmann TJ; Wetsel RA; Actor JK
Scand J Immunol; 2005 Aug; 62(2):123-30. PubMed ID: 16101818
[TBL] [Abstract][Full Text] [Related]
26. Synergy between tumor necrosis factor and bacterial products causes hemorrhagic necrosis and lethal shock in normal mice.
Rothstein JL; Schreiber H
Proc Natl Acad Sci U S A; 1988 Jan; 85(2):607-11. PubMed ID: 3422444
[TBL] [Abstract][Full Text] [Related]
27. The fifth component of complement (C5) in the mouse. Analysis of the molecular basis for deficiency.
Wheat WH; Wetsel R; Falus A; Tack BF; Strunk RC
J Exp Med; 1987 May; 165(5):1442-7. PubMed ID: 3572304
[TBL] [Abstract][Full Text] [Related]
28. Cleavage of the fifth component of human complement and release of a split product with C5a-like activity by crystalline silica through free radical generation and kallikrein activation.
Governa M; Fenoglio I; Amati M; Valentino M; Bolognini L; Coloccini S; Volpe AR; Carmignani M; Fubini B
Toxicol Appl Pharmacol; 2002 Mar; 179(3):129-36. PubMed ID: 11906242
[TBL] [Abstract][Full Text] [Related]
29. C5a stimulates secretion of tumor necrosis factor from human mononuclear cells in vitro. Comparison with secretion of interleukin 1 beta and interleukin 1 alpha.
Okusawa S; Yancey KB; van der Meer JW; Endres S; Lonnemann G; Hefter K; Frank MM; Burke JF; Dinarello CA; Gelfand JA
J Exp Med; 1988 Jul; 168(1):443-8. PubMed ID: 3260938
[TBL] [Abstract][Full Text] [Related]
30. Role for C5 and neutrophils in the pulmonary intravascular clearance of circulating Cryptococcus neoformans.
Lovchik JA; Lipscomb MF
Am J Respir Cell Mol Biol; 1993 Dec; 9(6):617-27. PubMed ID: 8257594
[TBL] [Abstract][Full Text] [Related]
31. Pulmonary alveolar type II epithelial cells synthesize and secrete proteins of the classical and alternative complement pathways.
Strunk RC; Eidlen DM; Mason RJ
J Clin Invest; 1988 May; 81(5):1419-26. PubMed ID: 2966814
[TBL] [Abstract][Full Text] [Related]
32. Experimental Toxoplasma gondii infection in mice: the role of the fifth component of complement.
Araujo FG; Rosenberg LT; Remington JS
Proc Soc Exp Biol Med; 1975 Jul; 149(3):800-4. PubMed ID: 1144466
[TBL] [Abstract][Full Text] [Related]
33. Complement inhibition with an anti-C5 monoclonal antibody prevents acute cardiac tissue injury in an ex vivo model of pig-to-human xenotransplantation.
Kroshus TJ; Rollins SA; Dalmasso AP; Elliott EA; Matis LA; Squinto SP; Bolman RM
Transplantation; 1995 Dec; 60(11):1194-202. PubMed ID: 8525509
[TBL] [Abstract][Full Text] [Related]
34. Preparation and characterization of monoclonal antibodies against the fifth component of rabbit complement (C5).
Giclas PC; Baker SL; Gillespie ML; Wilcox C
J Immunol Methods; 1987 Dec; 105(2):201-9. PubMed ID: 3693908
[TBL] [Abstract][Full Text] [Related]
35. Role of IgG and complement component C5 in the initial course of experimental cryptococcosis.
Dromer F; Perronne C; Barge J; Vilde JL; Yeni P
Clin Exp Immunol; 1989 Dec; 78(3):412-7. PubMed ID: 2612053
[TBL] [Abstract][Full Text] [Related]
36. Terminal complement components play a role in the expression of C5a.
Gresham HD; Renfer L; Hammer CH; Frank MM
J Immunol; 1987 Feb; 138(3):838-41. PubMed ID: 3805718
[TBL] [Abstract][Full Text] [Related]
37. Hereditary deficiency of the fifth component of complement in man. I. Clinical, immunochemical, and family studies.
Rosenfeld SI; Kelly ME; Leddy JP
J Clin Invest; 1976 Jun; 57(6):1626-34. PubMed ID: 932197
[TBL] [Abstract][Full Text] [Related]
38. Tritiated thymidine incorporation and the development of an interstitial lesion in the bronchiolar-alveolar regions of the lungs of normal and complement deficient mice after inhalation of chrysotile asbestos.
McGavran PD; Butterick CJ; Brody AR
J Environ Pathol Toxicol Oncol; 1989 Dec; 9(5-6):377-91. PubMed ID: 2637933
[TBL] [Abstract][Full Text] [Related]
39. Deficiency of complement factor C5 reduces early mortality but does not prevent organ damage in an animal model of multiple organ dysfunction syndrome.
Nieuwenhuijzen GA; Meyer MP; Hendriks T; Goris RJ
Crit Care Med; 1995 Oct; 23(10):1686-93. PubMed ID: 7587234
[TBL] [Abstract][Full Text] [Related]
40. Mice naturally tolerant to C5 have T cells that suppress the response to this antigen.
Cairns L; Rosen FS; Borel Y
Eur J Immunol; 1986 Oct; 16(10):1277-82. PubMed ID: 2945729
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
